{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:49Z","timestamp":1792787869758,"version":"4.5.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funded by the Institutional Development Support Program of the Brazilian Unified Health System (Proadi-SUS), Ministry of Health, in partnership with Hospital Israelita Albert Einstein (HIAE).","id":[{"id":"https:\/\/ror.org\/04cwrbc27","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To map and describe the capillary blood\u2013based technologies employed to measure glycated hemoglobin (HbA1c) in epidemiological studies, focusing on their accuracy, applicability, feasibility, and implementation barriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The development of technologies for diabetes screening and monitoring has expanded, particularly in decentralized and epidemiological contexts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A scoping review was conducted in accordance with PRISMA-ScR guidelines. A comprehensive literature search was performed in Embase, Scopus, Web of Science, LILACS, and CINAHL between 18 and 24 February 2025. The search was conducted without restrictions on language, publication year, or geographic location, retrieving studies indexed up to 31 January 2025. We included primary epidemiological studies involving adults (\u2265\u200918 years) that assessed HbA1c measurement using capillary blood technologies or approaches in field or population-based settings. Studies exclusively evaluating capillary glucometers, continuous glucose monitoring, or oral glucose tolerance tests were excluded. Two reviewers independently screened records and assessed full-text eligibility against pre-specified criteria registered on the Open Science Framework (OSF). Data were extracted and synthesized descriptively based on outcomes reported by the original study authors and categorized in regard to the aim.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 2,238 records screened, 106 studies were included. Fifteen distinct analytical technologies for HbA1c measurement using capillary blood were identified, with Point-of-Care Testing (PoCT) devices representing the predominant category. Among studies reporting diagnostic accuracy metrics, sensitivity ranged from 17.4% to 100% and specificity from 43.5% to 99.1%. PoCT devices required 2\u201310 \u00b5L of capillary blood and produced results within minutes. Applicability findings described portability, limited training requirements, and use in decentralized settings. Dried Blood Spot (DBS) approaches facilitated remote collection and mailing to reference laboratories. Reported challenges included variability in analytical performance, limited validation in Low- and Middle-Income Countries (LMICs), and operational constraints related to cost, supply logistics, and integration into health systems. Overall, 77% of included studies were conducted in High-Income Countries (HICs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Capillary blood\u2013based technologies for HbA1c measurement have been applied across diverse epidemiological contexts, with reported analytical and operational characteristics consistent with decentralized use. Nevertheless, the evidence remains geographically concentrated and heterogeneous, indicating gaps in research from LMICs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-026-02410-y","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:14:55Z","timestamp":1783761295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HbA1c measurement using capillary blood in epidemiological studies: a scoping review of technologies and approaches"],"prefix":"10.1186","volume":"26","author":[{"given":"Bruna Suellen","family":"Breternitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Queiroz","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna Terezinha","family":"Rother","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Barone","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Carvalho","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz","family":"Menezes-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Geovanni","family":"Enriquez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"de Oliveira Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Lacerda","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Duim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"10397","key":"2410_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203\u201334.","journal-title":"Lancet"},{"issue":"10397","key":"2410_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0140-6736(23)00914-5","volume":"402","author":"AF Walker","year":"2023","unstructured":"Walker AF, Graham S, Maple-Brown L, Egede LE, Campbell JA, Walker RJ, et al. Interventions to address global inequity in diabetes: international progress. Lancet. 2023;402(10397):250\u201364.","journal-title":"Lancet"},{"issue":"10467","key":"2410_CR3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1 108 population-representative studies. Lancet. 2024;404(10467):2077\u201393.","journal-title":"Lancet"},{"key":"2410_CR4","volume-title":"Panorama of Diabetes in the Americas 2024","author":"Pan American Health Organization (PAHO)","year":"2024","unstructured":"Pan American Health Organization (PAHO). Panorama of Diabetes in the Americas 2024. Washington (DC): PAHO; 2024."},{"issue":"1","key":"2410_CR5","first-page":"1","volume":"64","author":"CE Ferreira","year":"2018","unstructured":"Ferreira CE, Guerra JC, Slhessarenko N, Scartezini M, Franca CN, Colombini MP, et al. Point-of-care testing: general aspects. Clin Lab. 2018;64(1):1\u20139.","journal-title":"Clin Lab"},{"key":"2410_CR6","volume-title":"Pesquisa Nacional de Sa\u00fade 2019: percep\u00e7\u00e3o do estado de sa\u00fade, estilos de vida e doen\u00e7as cr\u00f4nicas","author":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE)","year":"2020","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE). Pesquisa Nacional de Sa\u00fade 2019: percep\u00e7\u00e3o do estado de sa\u00fade, estilos de vida e doen\u00e7as cr\u00f4nicas. Rio de Janeiro: IBGE; 2020."},{"key":"2410_CR7","volume-title":"Minist\u00e9rio da Sa\u00fade. Pesquisa Nacional por Amostra de Domic\u00edlios Cont\u00ednua 2019 \u2013 Acesso \u00e0 sa\u00fade","author":"Brasil","year":"2019","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Pesquisa Nacional por Amostra de Domic\u00edlios Cont\u00ednua 2019 \u2013 Acesso \u00e0 sa\u00fade. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2019."},{"issue":"Supplement1","key":"2410_CR8","first-page":"S1","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"ElSayed NA, Aleppo G, Bannuru RR, Beverly EA, Bruemmer D, Collins BS, et al. American Diabetes Association Professional Practice Committee. Introduction and Methodology: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Supplement1):S1\u20134.","journal-title":"Diabetes Care"},{"key":"2410_CR9","volume-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation","author":"World Health Organization (WHO)","year":"2006","unstructured":"World Health Organization (WHO). Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation. Geneva: WHO; 2006."},{"issue":"11","key":"2410_CR10","doi-asserted-by":"publisher","first-page":"e0242415","DOI":"10.1371\/journal.pone.0242415","volume":"15","author":"G Kaur","year":"2020","unstructured":"Kaur G, Lakshmi PV, Rastogi A, Bhansali A, Jain S, Teerawattananon Y, et al. Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis. PLoS ONE. 2020;15(11):e0242415.","journal-title":"PLoS ONE"},{"issue":"2","key":"2410_CR11","doi-asserted-by":"publisher","first-page":"e002527","DOI":"10.1136\/bmjdrc-2021-002527","volume":"9","author":"J Cross","year":"2021","unstructured":"Cross J, Sharma S, John WG, Rayman G. Validation and feasibility of a postal system for remote monitoring of HbA1c. BMJ Open Diabetes Res Care. 2021;9(2):e002527.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"2410_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12939-023-01878-7","volume":"22","author":"H Gallardo-Rinc\u00f3n","year":"2023","unstructured":"Gallardo-Rinc\u00f3n H, R\u00edos-Blancas MJ, Montoya A, Saucedo-Mart\u00ednez R, Morales-Ju\u00e1rez L, Mujica R, et al. Evaluation of effective coverage for type 2 diabetes in Mexican primary care health information systems: a retrospective registry analysis. Int J Equity Health. 2023;22(1):61.","journal-title":"Int J Equity Health"},{"issue":"3","key":"2410_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2337\/dc09-1410","volume":"33","author":"X Zhou","year":"2010","unstructured":"Zhou X, Pang Z, Gao W, Wang S, Zhang L, Ning F, et al. Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China. Diabetes Care. 2010;33(3):545\u201350.","journal-title":"Diabetes Care"},{"issue":"1","key":"2410_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/19485565.2014.901885","volume":"60","author":"E Crimmins","year":"2014","unstructured":"Crimmins E, Kim JK, McCreath H, Faul J, Weir D, Seeman T. Validation of blood-based assays using dried blood spots for use in large population studies. Biodemography Soc Biol. 2014;60(1):38\u201348.","journal-title":"Biodemography Soc Biol"},{"issue":"1","key":"2410_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pcd.2023.10.011","volume":"18","author":"A Gourlay","year":"2024","unstructured":"Gourlay A, Sutherland CD, Radley A. Point-of-care testing of HbA1c levels in community settings for people with established diabetes or at risk: a systematic review and meta-analysis. Prim Care Diabetes. 2024;18(1):7\u201316.","journal-title":"Prim Care Diabetes"},{"key":"2410_CR16","first-page":"102057","volume":"70","author":"LM Moore","year":"2025","unstructured":"Moore LM, Chen X, Smith A, et al. Point-of-care HbA1c screening in population health programmes: coverage gains and equity impacts. Int J Public Health. 2025;70:102057.","journal-title":"Int J Public Health"},{"key":"2410_CR17","doi-asserted-by":"publisher","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI manual for evidence synthesis. JBI; 2024. Available from: https:\/\/synthesismanual.jbi.global. https:\/\/doi.org\/10.46658\/JBIMES-24-01","DOI":"10.46658\/JBIMES-24-01"},{"issue":"7","key":"2410_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and Explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"2410_CR19","doi-asserted-by":"publisher","unstructured":"Breternitz BS, Ara\u00fajo RQ, Ferrer ML, Duim E. Use of technologies based on capillary blood collection to assess Diabetes mellitus in epidemiological studies: a scoping review [Internet]. OSF; 2025 [cited 2025 Aug 28]. Available from: https:\/\/doi.org\/10.17605\/OSF.IO\/39Q8T.","DOI":"10.17605\/OSF.IO\/39Q8T"},{"issue":"2","key":"2410_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2337\/diacare.19.2.142","volume":"19","author":"JO Jeppsson","year":"1996","unstructured":"Jeppsson JO, Jerntorp P, Alm\u00ebr LO, Persson R, Ekberg G, Sundkvist G. Capillary blood on filter paper for determination of HbA1c by ion exchange chromatography. Diabetes Care. 1996;19(2):142\u20135.","journal-title":"Diabetes Care"},{"issue":"10","key":"2410_CR21","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1515\/CCLM.2009.274","volume":"47","author":"MR Fokkema","year":"2009","unstructured":"Fokkema MR, Bakker AJ, de Boer F, Kooistra J, de Vries S, Wolthuis A. HbA1c measurements from dried blood spots: validation and patient satisfaction. Clin Chem Lab Med. 2009;47(10):1259\u201364.","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"2410_CR22","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.annepidem.2014.09.010","volume":"24","author":"QC Nguyen","year":"2014","unstructured":"Nguyen QC, Whitsel EA, Tabor JW, Cuthbertson CC, Wener MH, Potter AJ, et al. Blood spot-based measures of glucose homeostasis and diabetes prevalence in a nationally representative population of young US adults. Ann Epidemiol. 2014;24(12):903\u2013e91.","journal-title":"Ann Epidemiol"},{"key":"2410_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cca.2015.03.028","volume":"445","author":"IM Miller","year":"2015","unstructured":"Miller IM, Lacher DA, Chen TC, Zipf GW, Gindi RM, Galinsky AM, et al. Collection and laboratory methods for dried blood spots for hemoglobin A1c and total and high-density lipoprotein cholesterol in population-based surveys. Clin Chim Acta. 2015;445:143\u201354.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2410_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12907-015-0013-5","volume":"15","author":"CA Mastronardi","year":"2015","unstructured":"Mastronardi CA, Whittle B, Tunningley R, Neeman T, Paz-Filho G. The use of dried blood spot sampling for the measurement of HbA1c: a cross-sectional study. BMC Clin Pathol. 2015;15(1):13.","journal-title":"BMC Clin Pathol"},{"issue":"4","key":"2410_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jcjd.2017.10.053","volume":"42","author":"TG Elliott","year":"2018","unstructured":"Elliott TG, Dooley KC, Zhang M, Campbell HSD, Thompson DJS. Comparison of Glycated Hemoglobin Results Based on At-Home and In-Lab Dried Blood Spot Sampling to Routine Venous Blood Sampling In-Lab in Adult Patients With Type 1 or Type 2 Diabetes. Can J Diabetes. 2018;42(4):426\u2013e4321.","journal-title":"Can J Diabetes"},{"issue":"9","key":"2410_CR26","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/dme.14110","volume":"37","author":"JM Hall","year":"2020","unstructured":"Hall JM, Fowler CF, Barrett F, Humphry RW, Van Drimmelen M, MacRury SM. HbA1c determination from HemaSpot\u2122 blood collection devices: comparison of home prepared dried blood spots with standard venous blood analysis. Diabet Med. 2020;37(9):1463\u201370.","journal-title":"Diabet Med"},{"issue":"8","key":"2410_CR27","doi-asserted-by":"publisher","first-page":"e14897","DOI":"10.1111\/dme.14897","volume":"39","author":"WN Groenendijk","year":"2022","unstructured":"Groenendijk WN, Griffin TP, Islam MN, Blake L, Wall D, Bell M, et al. Remote capillary blood collection for HbA1c measurement during the COVID-19 pandemic: A laboratory and patient perspective. Diabet Med. 2022;39(8):e14897.","journal-title":"Diabet Med"},{"issue":"11","key":"2410_CR28","doi-asserted-by":"publisher","first-page":"e0257154","DOI":"10.1371\/journal.pone.0257154","volume":"16","author":"DM Nathan","year":"2021","unstructured":"Nathan DM, Krause-Steinrauf H, Braffett BH, Arends VL, Younes N, McGee P, Research Group; DCCT\/EDIC Research Group. Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies. PLoS ONE. 2021;16(11):e0257154.","journal-title":"PLoS ONE"},{"issue":"5","key":"2410_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1331\/JAPhA.2011.09229","volume":"51","author":"OO Oyetayo","year":"2011","unstructured":"Oyetayo OO, James C, Martinez A, Roberson K, Talbert RL. The Hispanic Diabetes Management Program: impact of community pharmacists on clinical outcomes. J Am Pharm Assoc (Wash DC). 2011;51(5):623\u20136.","journal-title":"J Am Pharm Assoc (Wash DC)"},{"issue":"11","key":"2410_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/ijerph14111363","volume":"14","author":"T Kristensen","year":"2017","unstructured":"Kristensen T, Waldorff FB, Nex\u00f8e J, Skovsgaard CV, Olsen KR. Variation in point-of-care testing of HbA1c in diabetes care in general practice. Int J Environ Res Public Health. 2017;14(11):342\u20139.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"2410_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1370\/afm.2035","volume":"15","author":"HP Whitley","year":"2017","unstructured":"Whitley HP, Hanson C, Parton JM. Systematic diabetes screening using point-of-care HbA1c testing facilitates identification of prediabetes. Ann Fam Med. 2017;15(2):162\u20134.","journal-title":"Ann Fam Med"},{"issue":"7","key":"2410_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5588\/ijtld.21.0013","volume":"25","author":"A Largen","year":"2021","unstructured":"Largen A, Ayala A, Khurana R, Katz DJ, Venkatappa TK, Brostrom R, Tuberculosis Epidemiologic Studies Consortium. Evaluation of point-of-care algorithms to detect diabetes during screening for latent TB infection. Int J Tuberc Lung Dis. 2021;25(7):547\u201353.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"2410_CR33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.amepre.2023.11.010","volume":"66","author":"AE Burch","year":"2024","unstructured":"Burch AE, Lee E, Bolin LP, Shackelford P, Bolin P. Health screening among a rural, hourly workforce: north Carolina SERVIRE project. Am J Prev Med. 2024;66(4):730\u20134.","journal-title":"Am J Prev Med"},{"issue":"12","key":"2410_CR34","doi-asserted-by":"publisher","first-page":"e093780","DOI":"10.1136\/bmjopen-2024-093780","volume":"14","author":"R Markwart","year":"2024","unstructured":"Markwart R, Storch J, Bleidorn J, Freytag A. Utilisation and trends of laboratory testing and point-of-care testing in primary care in Germany: an analysis of claims data. BMJ Open. 2024;14(12):e093780.","journal-title":"BMJ Open"},{"issue":"6","key":"2410_CR35","doi-asserted-by":"publisher","first-page":"e0276949","DOI":"10.1371\/journal.pone.0276949","volume":"18","author":"K Boonprasert","year":"2023","unstructured":"Boonprasert K, Tharavanij T, Pechyen C, Ponsanti K, Tangnorawich B, Viyanant V, Na-Bangchang K. Validation of an electrochemical sensor based on gold nanoparticles as a point-of-care test for quantitative determination of glycated hemoglobin. PLoS ONE. 2023;18(6):e0276949.","journal-title":"PLoS ONE"},{"issue":"11","key":"2410_CR36","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.2337\/diacare.15.11.1494","volume":"15","author":"R Guthrie","year":"1992","unstructured":"Guthrie R, Hellman R, Kilo C, Hiar CE, Crowley LE, Childs B, et al. A multisite physician\u2019s office laboratory evaluation of an immunological method for the measurement of HbA1c. Diabetes Care. 1992;15(11):1494\u20138.","journal-title":"Diabetes Care"},{"issue":"7","key":"2410_CR37","doi-asserted-by":"publisher","first-page":"764","DOI":"10.2337\/diacare.19.7.764","volume":"19","author":"JS Carter","year":"1996","unstructured":"Carter JS, Houston CA, Gilliland SS, Perez GE, Owen CL, Pathak DR, et al. Rapid HbA1c testing in a community setting. Diabetes Care. 1996;19(7):764\u20137.","journal-title":"Diabetes Care"},{"issue":"4","key":"2410_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/152091599316946","volume":"1","author":"T Stevenson","year":"1999","unstructured":"Stevenson T. Glycosal: the first rapid, point-of-care test for the determination of hemoglobin A1c in patients with diabetes. Diabetes Technol Ther. 1999;1(4):425\u201331.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2410_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s005920070028","volume":"37","author":"MP Arsie","year":"2000","unstructured":"Arsie MP, Marchioro L, Lapolla A, Giacchetto GF, Bordin MR, Rizzotti P, et al. Evaluation of diagnostic reliability of DCA 2000 for rapid and simple monitoring of HbA1c. Acta Diabetol. 2000;37(1):1\u20137.","journal-title":"Acta Diabetol"},{"issue":"1","key":"2410_CR40","first-page":"8","volume":"44","author":"RC Hawkins","year":"2003","unstructured":"Hawkins RC. Comparison of four point-of-care HbA1c analytical systems against central laboratory analysis. Singap Med J. 2003;44(1):8\u201311.","journal-title":"Singap Med J"},{"issue":"6","key":"2410_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/dia.2005.7.907","volume":"7","author":"L Kennedy","year":"2005","unstructured":"Kennedy L, Herman WH, GOAL A1C Study Team. Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study). Diabetes Technol Ther. 2005;7(6):907\u201312.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2410_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2296-6-28","volume":"6","author":"KL Schwartz","year":"2005","unstructured":"Schwartz KL, Monsur JC, Bartoces MG, West PA, Neale AV. Correlation of same-visit HbA1c test with laboratory-based measurements: a MetroNet study. BMC Fam Pract. 2005;6(1):28.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"2410_CR43","first-page":"371","volume":"5","author":"MD Shephard","year":"2005","unstructured":"Shephard MD, Mazzachi BC, Shephard AK, McLaughlin KJ, Denner B, Barnes G. The impact of point of care testing on diabetes services along Victoria\u2019s Mallee Track: results of a community-based diabetes risk assessment and management program. Rural Remote Health. 2005;5(3):371.","journal-title":"Rural Remote Health"},{"issue":"6","key":"2410_CR44","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1345\/aph.1E504","volume":"39","author":"DA Sicard","year":"2005","unstructured":"Sicard DA, Taylor JR. Comparison of point-of-care HbA1c test versus standardized laboratory testing. Ann Pharmacother. 2005;39(6):1024\u20138.","journal-title":"Ann Pharmacother"},{"issue":"528","key":"2410_CR45","first-page":"511","volume":"56","author":"K Khunti","year":"2006","unstructured":"Khunti K, Stone MA, Burden AC, Turner D, Raymond NT, Burden M, et al. Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus. Br J Gen Pract. 2006;56(528):511\u20137.","journal-title":"Br J Gen Pract"},{"issue":"12","key":"2410_CR46","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1553-2712.2008.00240.x","volume":"15","author":"AA Ginde","year":"2008","unstructured":"Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening. Acad Emerg Med. 2008;15(12):1241\u20137.","journal-title":"Acad Emerg Med"},{"issue":"3","key":"2410_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1108\/09526860810868256","volume":"21","author":"G Rust","year":"2008","unstructured":"Rust G, Gailor M, Daniels E, McMillan-Persaud B, Strothers H, Mayberry R. Point of care testing to improve glycemic control. Int J Health Care Qual Assur. 2008;21(3):325\u201335.","journal-title":"Int J Health Care Qual Assur"},{"issue":"11","key":"2410_CR48","doi-asserted-by":"publisher","first-page":"624","DOI":"10.5694\/j.1326-5377.2009.tb02590.x","volume":"190","author":"TK Bubner","year":"2009","unstructured":"Bubner TK, Laurence CO, Gialamas A, Yelland LN, Ryan P, Willson KJ, et al. Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial. Med J Aust. 2009;190(11):624\u20136.","journal-title":"Med J Aust"},{"issue":"4","key":"2410_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3122\/jabfm.2009.04.090057","volume":"22","author":"KL Schwartz","year":"2009","unstructured":"Schwartz KL, Monsur J, Hammad A, Bartoces MG, Neale AV. Comparison of point of care and laboratory HbA1c analysis: a MetroNet study. J Am Board Fam Med. 2009;22(4):461\u20133.","journal-title":"J Am Board Fam Med"},{"issue":"6","key":"2410_CR50","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1177\/193229681000400625","volume":"4","author":"A Chang","year":"2010","unstructured":"Chang A, Frank J, Knaebel J, Fullam J, Pardo S, Simmons DA. Evaluation of an over-the-counter glycated hemoglobin (A1C) test kit. J Diabetes Sci Technol. 2010;4(6):1495\u2013503.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2410_CR51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1742-6723.2010.01333.x","volume":"22","author":"GA Jelinek","year":"2010","unstructured":"Jelinek GA, Weiland TJ, Moore G, Tan G, Maslin M, Bowman K, et al. Screening for type 2 diabetes with random finger-prick glucose and bedside HbA1c in an Australian emergency department. Emerg Med Australas. 2010;22(5):427\u201334.","journal-title":"Emerg Med Australas"},{"key":"2410_CR52","doi-asserted-by":"crossref","unstructured":"Solet JL, Baroux N, Pochet M, Benoit-Cattin T, De Montera AM, Sissoko D, et al. Prevalence of type 2 diabetes and other cardiovascular risk factors in Mayotte in 2008: the MAYDIA study. Diabetes Metab. 2011;37(3):201\u20137.","DOI":"10.1016\/j.diabet.2010.09.007"},{"issue":"10","key":"2410_CR53","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.aprim.2010.09.017","volume":"43","author":"B Font","year":"2011","unstructured":"Font B, Laherrere E, Grimaldi A. Estudio de la determinaci\u00f3n de la hemoglobina glucosilada en pacientes com diabetes mellitus 2 em sangre capilar em um centro de atenci\u00f3n primaria. Aten Primarial. 2011;43(10):536\u201343.","journal-title":"Aten Primarial"},{"issue":"7","key":"2410_CR54","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/0022034511407069","volume":"90","author":"E Lalla","year":"2011","unstructured":"Lalla E, Kunzel C, Burkett S, Cheng B, Lamster IB. Identification of unrecognized diabetes and pre-diabetes in a dental setting. J Dent Res. 2011;90(7):855\u201360.","journal-title":"J Dent Res"},{"issue":"6","key":"2410_CR55","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1177\/193229681100500615","volume":"5","author":"MF Magee","year":"2011","unstructured":"Magee MF, Nassar C. Hemoglobin A1c testing in an emergency department. J Diabetes Sci Technol. 2011;5(6):1437\u201343.","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"2410_CR56","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1553-2712.2011.01014.x","volume":"18","author":"MD Menchine","year":"2011","unstructured":"Menchine MD, Arora S, Camargo CA Jr, Ginde AA. Prevalence of undiagnosed and suboptimally controlled diabetes by point-of-care HbA1C in unselected emergency department patients. Acad Emerg Med. 2011;18(3):326\u20139.","journal-title":"Acad Emerg Med"},{"key":"2410_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cca.2013.04.025","volume":"424","author":"B Crocker","year":"2013","unstructured":"Crocker B, Lewandrowski EL, Lewandrowski N, Gregory K, Lewandrowski K. Patient satisfaction with point-of-care laboratory testing: report of a quality improvement program in an ambulatory practice of an academic medical center. Clin Chim Acta. 2013;424:8\u201311.","journal-title":"Clin Chim Acta"},{"key":"2410_CR58","first-page":"21","volume":"21","author":"J Vella","year":"2013","unstructured":"Vella J, Azzopardi LM. Pharmacist-led diabetic patient monitoring. J Euromed Pharm. 2013;21:21\u20134.","journal-title":"J Euromed Pharm"},{"issue":"3","key":"2410_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1331\/JAPhA.2013.12102","volume":"53","author":"AM Wensil","year":"2013","unstructured":"Wensil AM, Smith JD, Pound MW, Herring C. Comparing point-of-care A1C and random plasma glucose for screening diabetes in migrant farm workers. J Am Pharm Assoc (Wash DC). 2013;53(3):261\u20136.","journal-title":"J Am Pharm Assoc (Wash DC)"},{"issue":"1","key":"2410_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.diabres.2013.12.030","volume":"104","author":"RW Mayega","year":"2014","unstructured":"Mayega RW, Guwatudde D, Makumbi FE, Nakwagala FN, Peterson S, Tomson G, et al. Comparison of fasting plasma glucose and haemoglobin A1c point-of-care tests in screening for diabetes and abnormal glucose regulation in a rural low income setting. Diabetes Res Clin Pract. 2014;104(1):112\u201320.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2410_CR61","first-page":"e23","volume":"37","author":"C Franck","year":"2014","unstructured":"Franck C, Marshall L, Gay E, Farr S, Brady J. Point-of-care HbA1c screening predicts diabetic retinopathy in an urban, minority population. Diabetes Care. 2014;37(2):e23\u20134.","journal-title":"Diabetes Care"},{"issue":"11","key":"2410_CR62","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/jcpe.12307","volume":"41","author":"IB Lamster","year":"2014","unstructured":"Lamster IB, Cheng B, Burkett S, Lalla E. Periodontal findings in individuals with newly identified pre-diabetes or diabetes mellitus. J Clin Periodontol. 2014;41(11):1055\u201360.","journal-title":"J Clin Periodontol"},{"issue":"1","key":"2410_CR63","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.diabres.2014.01.026","volume":"104","author":"S Pilleron","year":"2014","unstructured":"Pilleron S, Pasquier E, Boyoze-Nolasco I, Villafuerte JJ, Olchini D, Fontbonne A. Participative decentralization of diabetes care in Davao City (Philippines) according to the Chronic Care Model: a program evaluation. Diabetes Res Clin Pract. 2014;104(1):189\u201395.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2410_CR64","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1186\/1471-2458-14-929","volume":"14","author":"CP Rowan","year":"2014","unstructured":"Rowan CP, Miadovnik LA, Riddell MC, Rotondi MA, Gledhill N, Jamnik VK. Identifying persons at risk for developing type 2 diabetes in a concentrated population of high risk ethnicities in Canada using a risk assessment questionnaire and point-of-care capillary blood HbA1c measurement. BMC Public Health. 2014;14(1):929.","journal-title":"BMC Public Health"},{"issue":"4","key":"2410_CR65","first-page":"2849","volume":"14","author":"BA Spaeth","year":"2014","unstructured":"Spaeth BA, Shephard MD, Schatz S. Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care. Rural Remote Health. 2014;14(4):2849.","journal-title":"Rural Remote Health"},{"issue":"8","key":"2410_CR66","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.semerg.2014.01.012","volume":"40","author":"MC Villar-del-Campo","year":"2014","unstructured":"Villar-del-Campo MC, Rodr\u00edguez-Caravaca G, Gil-Yonte P, Cidoncha-Calder\u00f3n E, Garc\u00eda-Cruces M\u00e9ndez J, Donnay-P\u00e9rez S. Concordancia diagn\u00f3stica entre dos m\u00e9todos de detecci\u00f3n de hemoglobina glucosilada A1c en Atenci\u00f3n Primaria. Semergen. 2014;40(8):431\u20135.","journal-title":"Semergen"},{"issue":"6","key":"2410_CR67","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1590\/1516-3180.2013.9110911","volume":"133","author":"A Affret","year":"2015","unstructured":"Affret A, Griz LH, Cesse E\u00c2, Specht YS, Carvalho EM, Fontbonne A. Assessment of a glycated hemoglobin point-of-care analyzer (A1CNow+) in comparison with an immunoturbidimetric method: a diagnostic accuracy study. Sao Paulo Med J. 2015;133(6):460\u20134.","journal-title":"Sao Paulo Med J"},{"issue":"3","key":"2410_CR68","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.diabres.2015.09.004","volume":"110","author":"S Priscilla","year":"2015","unstructured":"Priscilla S, Nanditha A, Simon M, Satheesh K, Kumar S, Shetty AS, et al. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India-Outcome of screening. Diabetes Res Clin Pract. 2015;110(3):335\u201340.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2410_CR69","doi-asserted-by":"publisher","first-page":"902","DOI":"10.4314\/ahs.v15i3.26","volume":"15","author":"D Tanyanyiwa","year":"2015","unstructured":"Tanyanyiwa D, Dandara C, Bhana SA, Pauly B, Marule F, Ramokoka M, et al. Implementation of POCT in the diabetic clinic in a large hospital. Afr Health Sci. 2015;15(3):902\u20137.","journal-title":"Afr Health Sci"},{"issue":"1","key":"2410_CR70","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13104-015-1171-3","volume":"8","author":"RC Dawkins","year":"2015","unstructured":"Dawkins RC, Oliver GF, Sharma M, Pinto BM, Jeronimo B, Pereira B, et al. An estimation of the prevalence of diabetes mellitus and diabetic retinopathy in adults in Timor-Leste. BMC Res Notes. 2015;8(1):249.","journal-title":"BMC Res Notes"},{"issue":"2","key":"2410_CR71","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/idh.12140","volume":"14","author":"M Bossart","year":"2016","unstructured":"Bossart M, Calley KH, Gurenlian JR, Mason B, Ferguson RE, Peterson T. A pilot study of an HbA1c chairside screening protocol for diabetes in patients with chronic periodontitis: the dental hygienist\u2019s role. Int J Dent Hyg. 2016;14(2):98\u2013107.","journal-title":"Int J Dent Hyg"},{"issue":"1","key":"2410_CR72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/j.0022-0337.2016.80.1.tb06059.x","volume":"80","author":"L Giblin","year":"2016","unstructured":"Giblin L, Gaboury J, Lalla E, Lamster IB. Utilizing a diabetes risk test and A1c point-of-care instrument to identify increased risk for diabetes in an educational dental setting. J Dent Educ. 2016;80(1):65\u201372.","journal-title":"J Dent Educ"},{"issue":"3","key":"2410_CR73","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jcjd.2015.11.003","volume":"40","author":"J Mackenzie-Feder","year":"2016","unstructured":"Mackenzie-Feder J, Jin A, Seccombe DW, Sirrs S, Neufeld C, Dawson KG. Agreement of point-of-care capillary glycated hemoglobin levels with conventional screening tests for diabetes mellitus in a Canadian First Nations population. Can J Diabetes. 2016;40(3):242\u20136.","journal-title":"Can J Diabetes"},{"issue":"2","key":"2410_CR74","first-page":"455","volume":"48","author":"C Tantipoj","year":"2017","unstructured":"Tantipoj C, Sakoolnamarka SS, Supa-amornkul S, Lohsoonthorn V, Deerochanawong C, Khovidhunkit SP, et al. Screening for type 2 diabetes mellitus and prediabetes using point-of-care testing for HbA1c among Thai dental patients. Southeast Asian J Trop Med Public Health. 2017;48(2):455\u201365.","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"1","key":"2410_CR75","doi-asserted-by":"publisher","first-page":"e22172","DOI":"10.1002\/jcla.22172","volume":"32","author":"R Zhou","year":"2018","unstructured":"Zhou R, Wang W, Song ZX, Tong Q, Wang QT. Evaluation of a new hemoglobin A1c analyzer for point-of-care testing. J Clin Lab Anal. 2018;32(1):e22172.","journal-title":"J Clin Lab Anal"},{"key":"2410_CR76","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.diabres.2017.05.014","volume":"130","author":"JA Hirst","year":"2017","unstructured":"Hirst JA, Stevens RJ, Smith I, James T, Gudgin BC, Farmer AJ. How can point-of-care HbA1c testing be integrated into UK primary care consultations? - A feasibility study. Diabetes Res Clin Pract. 2017;130:113\u201320.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2410_CR77","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/0004563216661737","volume":"54","author":"A Jain","year":"2017","unstructured":"Jain A, Rao N, Sharifi M, Bhatt N, Patel P, Nirmal D, et al. Evaluation of the point of care Afinion AS100 analyser in a community setting. Ann Clin Biochem. 2017;54(3):331\u201341.","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"2410_CR78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.pcd.2016.09.008","volume":"11","author":"LA Motta","year":"2017","unstructured":"Motta LA, Shephard MD, Brink J, Lawson S, Rheeder P. Point-of-care testing improves diabetes management in a primary care clinic in South Africa. Prim Care Diabetes. 2017;11(3):248\u201353.","journal-title":"Prim Care Diabetes"},{"issue":"3","key":"2410_CR79","first-page":"310","volume":"139","author":"SD Pastakia","year":"2017","unstructured":"Pastakia SD, Njuguna B, Onyango BA, Washington S, Christoffersen-Deb A, Vedanthan R, et al. Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point-of-care HbA1c to glucose testing. Int J Gynaecol Obstet. 2017;139(3):310\u20137.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"2410_CR80","doi-asserted-by":"publisher","first-page":"e0174504","DOI":"10.1371\/journal.pone.0174504","volume":"12","author":"S Wells","year":"2017","unstructured":"Wells S, Rafter N, Kenealy T, Herd G, Eggleton K, Lightfoot R, et al. The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation. PLoS ONE. 2017;12(4):e0174504.","journal-title":"PLoS ONE"},{"issue":"3","key":"2410_CR81","first-page":"189","volume":"38","author":"SE Fellows","year":"2019","unstructured":"Fellows SE, Cipriano GC. Variation between Point-of-care and Laboratory HbA1c testing in Clinical Practice. P R Health Sci J. 2019;38(3):189\u201391.","journal-title":"P R Health Sci J"},{"issue":"6","key":"2410_CR82","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/ajo.12786","volume":"58","author":"K Culliney","year":"2018","unstructured":"Culliney K, McCowan LM, Okesene-Gafa K, Murphy R, Rowan J, Taylor RS, HUMBA Study Group, et al. Accuracy of point-of-care HbA1c testing in pregnant women. Aust N Z J Obstet Gynaecol. 2018;58(6):643\u20137.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"11","key":"2410_CR83","doi-asserted-by":"publisher","first-page":"738","DOI":"10.2471\/BLT.17.206227","volume":"96","author":"D Grint","year":"2018","unstructured":"Grint D, Alisjhabana B, Ugarte-Gil C, Riza AL, Walzl G, Pearson F, et al. TANDEM consortium. Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa. Bull World Health Organ. 2018;96(11):738\u201349.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"2410_CR84","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/met.2017.0098","volume":"16","author":"L Lynn","year":"2018","unstructured":"Lynn L, Kay D, Younes N, Sen S, Jain V. Accuracy and the Proper Use of the Point-of-Care Analysis in Hemoglobin A1C Measurement. Metab Syndr Relat Disord. 2018;16(3):117\u201321.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"2410_CR85","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13063-018-2459-0","volume":"19","author":"S Paglialunga","year":"2018","unstructured":"Paglialunga S, Bond R, Jaycox SH. Evaluation of HbA1c screening during outreach events for prediabetes subject recruitment for clinical research. Trials. 2018;19(1):60.","journal-title":"Trials"},{"issue":"3","key":"2410_CR86","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/1932296818759690","volume":"12","author":"KH Patzer","year":"2018","unstructured":"Patzer KH, Ardjomand P, G\u00f6hring K, Klempt G, Patzelt A, Redzich M, et al. Implementation of HbA1c point of care testing in 3 German medical practices: impact on workflow and physician, staff, and patient satisfaction. J Diabetes Sci Technol. 2018;12(3):687\u201394.","journal-title":"J Diabetes Sci Technol"},{"key":"2410_CR87","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.diabres.2018.03.036","volume":"140","author":"AS Veyhe","year":"2018","unstructured":"Veyhe AS, Andreassen J, Halling J, Grandjean P, Petersen MS, Weihe P. Prevalence of type 2 diabetes and prediabetes in the Faroe Islands. Diabetes Res Clin Pract. 2018;140:162\u201373.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2410_CR88","doi-asserted-by":"publisher","first-page":"020705","DOI":"10.11613\/BM.2018.020705","volume":"28","author":"Y Wang","year":"2018","unstructured":"Wang Y, Peng W, Tang J, Dong L, Gu C, Zhang X, et al. Verification of a novel point-of-care HbA1c device in real world clinical practice by comparison to three high performance liquid chromatography instruments. Biochem Med (Zagreb). 2018;28(2):020705.","journal-title":"Biochem Med (Zagreb)"},{"issue":"6","key":"2410_CR89","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.aucc.2018.11.064","volume":"32","author":"LM Weinel","year":"2019","unstructured":"Weinel LM, Summers MJ, Finnis ME, Poole A, Kar P, Chapman MJ, et al. Are point-of-care measurements of glycated haemoglobin accurate in the critically ill? Aust Crit Care. 2019;32(6):465\u201370.","journal-title":"Aust Crit Care"},{"key":"2410_CR90","doi-asserted-by":"publisher","first-page":"e031246","DOI":"10.1136\/bmjopen-2019-031246","volume":"9","author":"HT Alzubaidi","year":"2019","unstructured":"Alzubaidi HT, Chandir S, Hasan S, McNamara K, Cox R, Krass I. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study. BMJ Open. 2019;9:e031246.","journal-title":"BMJ Open"},{"key":"2410_CR91","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/gheg.2019.6","volume":"4","author":"S Malcolm","year":"2019","unstructured":"Malcolm S, Cadet J, Crompton L, DeGennaro V Jr. A model for point of care testing for non-communicable disease diagnosis in resource-limited countries. Glob Health Epidemiol Genom. 2019;4:e7.","journal-title":"Glob Health Epidemiol Genom"},{"issue":"12","key":"2410_CR92","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1007\/s00784-019-02888-y","volume":"23","author":"M Mataftsi","year":"2019","unstructured":"Mataftsi M, Koukos G, Sakellari D. Prevalence of undiagnosed diabetes and pre-diabetes in chronic periodontitis patients assessed by an HbA1c chairside screening protocol. Clin Oral Investig. 2019;23(12):4365\u201370.","journal-title":"Clin Oral Investig"},{"issue":"6","key":"2410_CR93","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s10877-019-00255-6","volume":"33","author":"F van Raalten","year":"2019","unstructured":"van Raalten F, Hiemstra YL, Keulen N, van Duivenvoorde Y, Stoecklein K, Verhagen EA, et al. Level of agreement of point-of-care and laboratory HbA1c measurements in the preoperative outpatient clinic in non-diabetic patients who are overweight or obese. J Clin Monit Comput. 2019;33(6):1139\u201344.","journal-title":"J Clin Monit Comput"},{"issue":"5","key":"2410_CR94","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1177\/1932296819831273","volume":"14","author":"WD Arnold","year":"2020","unstructured":"Arnold WD, Kupfer K, Hvidsten Swensen M, Fortner KS, Bays HE, Davis M, et al. Fingerstick precision and total error of a point-of-care HbA1c test. J Diabetes Sci Technol. 2020;14(5):890\u20135.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2410_CR95","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/1932296819831292","volume":"14","author":"WD Arnold","year":"2020","unstructured":"Arnold WD, Kupfer K, Little RR, Amar M, Horowitz B, Godbole N, et al. Accuracy and precision of a point-of-care HbA1c test. J Diabetes Sci Technol. 2020;14(5):883\u20139.","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"2410_CR96","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.pcd.2019.11.006","volume":"14","author":"M Barroso","year":"2020","unstructured":"Barroso M, Baena-D\u00edez JM, Mu\u00f1oz-Aguayo D, D\u00edaz JL, Schr\u00f6der H, Grau M. Reference ranges of glycated hemoglobin (HbA1c) in capillary blood in the Spanish population. Prim Care Diabetes. 2020;14(6):768\u201371.","journal-title":"Prim Care Diabetes"},{"key":"2410_CR97","doi-asserted-by":"publisher","first-page":"2037565","DOI":"10.1155\/2020\/2037565","volume":"2020","author":"A Berbudi","year":"2020","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Performance of point-of-care testing compared with the standard laboratory diagnostic test in the measurement of HbA1c in Indonesian Diabetic and Nondiabetic Subjects. J Diabetes Res. 2020;2020:2037565.","journal-title":"J Diabetes Res"},{"issue":"3","key":"2410_CR98","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/jcpe.13408","volume":"48","author":"E Montero","year":"2021","unstructured":"Montero E, Matesanz P, Nobili A, Luis Herrera-Pombo J, Sanz M, Guerrero A, et al. SEPA Research Network of Dental Clinics. Screening of undiagnosed hyperglycaemia in the dental setting: the DiabetRisk study. A field trial. J Clin Periodontol. 2021;48(3):378\u201388.","journal-title":"J Clin Periodontol"},{"issue":"3","key":"2410_CR99","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1353\/cpr.2020.0038","volume":"14","author":"M Smith","year":"2020","unstructured":"Smith M, Rosenmoss S, Seligman HK. Point-of-care hemoglobin A1c testing system in community settings: challenges, opportunities, and measurement characteristics. Prog Community Health Partnersh. 2020;14(3):327\u201335.","journal-title":"Prog Community Health Partnersh"},{"key":"2410_CR100","doi-asserted-by":"publisher","first-page":"e14598","DOI":"10.1111\/dme.14598","volume":"00","author":"H Alzubaidi","year":"2021","unstructured":"Alzubaidi H, Hasan S, Saidawi W, Mc Namara K, Chandir S, Krass I. Outcomes of a novel pharmacy screening intervention to address the burden of type 2 diabetes and cardiovascular disease in an Arabic-speaking country. Diabet Med. 2021;00:e14598.","journal-title":"Diabet Med"},{"key":"2410_CR101","doi-asserted-by":"publisher","first-page":"734306","DOI":"10.3389\/fmed.2021.734306","volume":"8","author":"MS Camargo","year":"2021","unstructured":"Camargo MS, Passos LCS, Mistro S, Soares DA, Kochergin CN, de Carvalho VCHDS, Macedo JCL, Cortes TBA, de Souza AA, Rumel D, Oliveira MG. Improving Access to the Glycated Hemoglobin Test in Rural Communities With Point-of-Care Devices: An Application Study. Front Med (Lausanne). 2021;8:734306.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"2410_CR102","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/1932296820972751","volume":"15","author":"JB Crocker","year":"2021","unstructured":"Crocker JB, Lynch SH, Guarino AJ, Lewandrowski K. The Impact of Point-of-Care Hemoglobin A1c Testing on Population Health-Based Onsite Testing Adherence: A Primary-Care Quality Improvement Study. J Diabetes Sci Technol. 2021;15(3):561\u20137.","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"2410_CR103","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1007\/s13300-021-01126-7","volume":"12","author":"AA Al Hayek","year":"2021","unstructured":"Al Hayek AA, Al-Saeed AH, Alzahrani WM, Al Dawish MA. Assessment of patient satisfaction with on-site point-of-care hemoglobin A1c testing: an observational study. Diabetes Ther. 2021;12(9):2531\u201344.","journal-title":"Diabetes Ther"},{"issue":"3","key":"2410_CR104","doi-asserted-by":"publisher","first-page":"e045511","DOI":"10.1136\/bmjopen-2020-045511","volume":"11","author":"JA Hirst","year":"2021","unstructured":"Hirst JA, Bobrow K, Farmer A, Morgan J, Levitt N. Point-of-care HbA1c testing in an urban primary care diabetes clinic in South Africa: a mixed methods feasibility study. BMJ Open. 2021;11(3):e045511.","journal-title":"BMJ Open"},{"key":"2410_CR105","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/OPTH.S287531","volume":"15","author":"S Mamtora","year":"2021","unstructured":"Mamtora S, Maghsoudlou P, Hasan H, Zhang W, El-Ashry M. Assessing the clinical utility of point of care HbA1c in the ophthalmology outpatient setting. Clin Ophthalmol. 2021;15:41\u20137.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"2410_CR106","doi-asserted-by":"publisher","first-page":"e00292","DOI":"10.1002\/edm2.292","volume":"4","author":"A Njoroge","year":"2021","unstructured":"Njoroge A, Augusto O, Page ST, Kigondu C, Oluka M, Puttkammer N, et al. Increased risk of prediabetes among virally suppressed adults with HIV in Central Kenya detected using glycated haemoglobin and fasting blood glucose. Endocrinol Diabetes Metab. 2021;4(4):e00292.","journal-title":"Endocrinol Diabetes Metab"},{"issue":"1","key":"2410_CR107","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1186\/s12879-021-06473-1","volume":"21","author":"RW Kubiak","year":"2021","unstructured":"Kubiak RW, Kratz M, Motala AA, Galagan S, Govere S, Brown ER, et al. Clinic-based diabetes screening at the time of HIV testing and associations with poor clinical outcomes in South Africa: a cohort study. BMC Infect Dis. 2021;21(1):789.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"2410_CR108","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.3390\/ijerph18126459","volume":"18","author":"M Suwattipong","year":"2021","unstructured":"Suwattipong M, Thuramonwong T, Tantipoj C, Fuangtharnthip P, Thanakun S, Khovidhunkit W, et al. Comparison of point-of-care testing and hospital-based methods in screening for potential type 2 diabetes mellitus and abnormal glucose regulation in a dental setting. Int J Environ Res Public Health. 2021;18(12):6459.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"2410_CR109","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/1753-6405.13181","volume":"46","author":"K Fleming","year":"2022","unstructured":"Fleming K, Weaver N, Peel R, Hure A, McEvoy M, Holliday E, Parsons M, Acharya S, Luu J, Wiggers J, Rissel C, Ranasinghe P, Jayawardena R, Samman S, Attia J. Using the AUSDRISK score to screen for pre-diabetes and diabetes in GP practices: a case-finding approach. Aust N Z J Public Health. 2022;46(2):203\u20137.","journal-title":"Aust N Z J Public Health"},{"issue":"5","key":"2410_CR110","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s13300-022-01240-0","volume":"13","author":"AA Al Hayek","year":"2022","unstructured":"Al Hayek AA, Sobki SH, Al-Saeed AH, Alzahrani WM, Al Dawish MA. Level of Agreement and Correlation Between the Estimated Hemoglobin A1c Results Derived by Continuous or Conventional Glucose Monitoring Systems Compared with the Point-of-Care or Laboratory-Based Measurements: An Observational Study. Diabetes Ther. 2022;13(5):953\u201367.","journal-title":"Diabetes Ther"},{"issue":"5","key":"2410_CR111","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.21873\/invivo.12952","volume":"36","author":"A V\u00e9gh","year":"2022","unstructured":"V\u00e9gh A, V\u00e9gh D, Banyai D, Kammerhofer G, Biczo Z, Voros B, et al. Point-of-care HbA1c measurements in oral cancer and control patients in Hungary. Vivo. 2022;36(5):2248\u201354.","journal-title":"Vivo"},{"issue":"4","key":"2410_CR112","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/26350106221100536","volume":"48","author":"J Woo","year":"2022","unstructured":"Woo J, Whyne EZ, Wright JI, Lehrer HM, Alhalimi TA, Wang T, et al. Feasibility and performance of hemoglobin A1c self-testing during COVID-19 among African Americans with type 2 diabetes. Sci Diabetes Self Manag Care. 2022;48(4):204\u201312.","journal-title":"Sci Diabetes Self Manag Care"},{"issue":"1","key":"2410_CR113","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12911-022-01999-z","volume":"22","author":"Z Yonel","year":"2022","unstructured":"Yonel Z, Kuningas K, Sharma P, Dutton M, Jalal Z, Cockwell P, et al. Concordance of three point of care testing devices with clinical chemistry laboratory standard assays and patient-reported outcomes of blood sampling methods. BMC Med Inf Decis Mak. 2022;22(1):248.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"2410_CR114","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1186\/s12913-023-10269-1","volume":"23","author":"I Krass","year":"2023","unstructured":"Krass I, Twigg MJ, Mitchell B, Wilson F, Mohebbi M, Trinder P, Shih STF, Carter R, Versace VL, McNamara K. Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial. BMC Health Serv Res. 2023;23(1):1337.","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"2410_CR115","doi-asserted-by":"publisher","first-page":"e15165","DOI":"10.1111\/dme.15165","volume":"40","author":"R Rajalakshmi","year":"2023","unstructured":"Rajalakshmi R, Vasconcelos JC, Prevost AT, Sivaprasad S, Deepa M, Raman R, SMART India Study Collaborators, et al. Burden of undiagnosed and suboptimally controlled diabetes in selected regions of India: results from the SMART India population-level diabetes screening study. Diabet Med. 2023;40(10):e15165.","journal-title":"Diabet Med"},{"issue":"4","key":"2410_CR116","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/00045632231219380","volume":"61","author":"A Radley","year":"2024","unstructured":"Radley A, Beer L, Rushdi D, Close H, McBurney S, Mackenzie A, et al. Implementation of point-of-care HbA1C instruments into community pharmacies: initial development of a pathway for robust community testing. Ann Clin Biochem. 2024;61(4):273\u201383.","journal-title":"Ann Clin Biochem"},{"key":"2410_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20101058241257264","volume":"33","author":"SSM Fan","year":"2024","unstructured":"Fan SSM, Koot D, Chua BM, Shu JH, Seah AC, Tan NC, et al. A study of the feasibility, ability and acceptability of self-testing of HbA1c before consultation (FLASH) in primary care setting. Proc Singap Healthc. 2024;33:1\u20136.","journal-title":"Proc Singap Healthc"},{"key":"2410_CR118","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.pcd.2024.09.005","volume":"18","author":"RA Casta\u00f1o","year":"2024","unstructured":"Casta\u00f1o RA, Granados MA, Trujillo N, Bernal JP, Trujillo JF, Trasmondi P, et al. Does performing a point-of-care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial. Prim Care Diabetes. 2024;18:624\u201331.","journal-title":"Prim Care Diabetes"},{"issue":"6","key":"2410_CR119","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jcjd.2024.03.008","volume":"48","author":"T Reed","year":"2024","unstructured":"Reed T, Scott S, Grewal E, Macavinta F, Tariq S, Campbell DJ. Estimating the rates of undiagnosed prediabetes and diabetes among people experiencing homelessness. Can J Diabetes. 2024;48(6):349\u201354.","journal-title":"Can J Diabetes"},{"issue":"1","key":"2410_CR120","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ijpp\/riad072","volume":"32","author":"CR Santana","year":"2024","unstructured":"Santana CR, de Oliveira MG, Camargo MS, Moreira PM, de Castro PR, Aguiar EC, et al. Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy. Int J Pharm Pract. 2024;32(1):46\u201351.","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"2410_CR121","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12913-024-11335-y","volume":"24","author":"J Serrano","year":"2024","unstructured":"Serrano J, Meyerowitz-Katz G, Dawson J, Ratnayake A, Ravi S, Dick H, et al. Integrating point-of-care diabetes detection with lifestyle counselling in community settings: outcomes from Western Sydney, Australia. BMC Health Serv Res. 2024;24(1):926.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"2410_CR122","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12875-024-02373-w","volume":"25","author":"S Tyagi","year":"2024","unstructured":"Tyagi S, Koh GC, Lee ES, Ong KP, Heng R, Er LH, et al. Primary Technology Enhanced Care Home HbA1c Testing (PTEC HAT) programme: a feasibility pilot study in Singapore. BMC Prim Care. 2024;25(1):127.","journal-title":"BMC Prim Care"},{"issue":"4","key":"2410_CR123","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/labmed\/lmad112","volume":"55","author":"H Weli","year":"2024","unstructured":"Weli H, Farnsworth CW. Implementing point-of-care hemoglobin A1C testing in an obstetrics outpatient clinic. Lab Med. 2024;55(4):464\u201370.","journal-title":"Lab Med"},{"issue":"3","key":"2410_CR124","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/jcpe.14090","volume":"52","author":"HK Chee","year":"2025","unstructured":"Chee HK, Abbas F, van Winkelhoff AJ, Tjakkes GH, Htoon HM, Li H, et al. Identifying undiagnosed diabetes and prediabetes in the dental setting in an Asian population: a clinical risk model. J Clin Periodontol. 2025;52(3):324\u201338.","journal-title":"J Clin Periodontol"},{"issue":"2","key":"2410_CR125","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1515\/cclm-2016-0303","volume":"55","author":"JA Hirst","year":"2017","unstructured":"Hirst JA, McLellan JH, Price CP, English E, Feakins BG, Stevens RJ, et al. Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis. Clin Chem Lab Med. 2017;55(2):167\u201380.","journal-title":"Clin Chem Lab Med"},{"key":"2410_CR126","unstructured":"International Diabetes Federation (IDF). IDF Diabetes Atlas. 11th ed. Brussels: IDF. 2025. Available from: https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025\/."},{"issue":"9642","key":"2410_CR127","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0140-6736(08)61404-X","volume":"372","author":"R Beaglehole","year":"2008","unstructured":"Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Ebrahim S, Kidd M, et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet. 2008;372(9642):940\u20139.","journal-title":"Lancet"},{"key":"2410_CR128","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.3389\/fphar.2020.588309","volume":"11","author":"LS Rosa","year":"2021","unstructured":"Rosa LS, Mistro S, Oliveira MG, Kochergin CN, Cortes ML, de Medeiros DS, et al. Cost-effectiveness of point-of-care A1C tests in a primary care setting. Front Pharmacol. 2021;11:5883.","journal-title":"Front Pharmacol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02410-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02410-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02410-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:25Z","timestamp":1791378145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02410-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":128,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02410-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"307"}}